Biophytis SA (BPTS) Stock Nose-Diving Since Announcement of Financial Results
Biophytis SA (BPTS), a clinical-stage biotechnology company, closed Wednesday’s regular trading session at $2.60 after gaining an increase of 2.77% during the day. However, in the premarket, BPTS stock has plunged 16.15% and is trading at $2.18 at the time of the writing. BPTS announced Financial Results The steep decline in the price of BPTS […]